APA (7th ed.) Citation

Ecker, J., Thatikonda, V., Sigismondo, G., Selt, F., Valinciute, G., Oehme, I., . . . Milde, T. (2021). Reduced chromatin binding of MYC is a key effect of HDAC inhibition in MYC amplified medulloblastoma. Neuro-Oncology, 23(2), . https://doi.org/10.1093/neuonc/noaa191

Chicago Style (17th ed.) Citation

Ecker, Jonas, et al. "Reduced Chromatin Binding of MYC Is a Key Effect of HDAC Inhibition in MYC Amplified Medulloblastoma." Neuro-Oncology 23, no. 2 (2021). https://doi.org/10.1093/neuonc/noaa191.

MLA (9th ed.) Citation

Ecker, Jonas, et al. "Reduced Chromatin Binding of MYC Is a Key Effect of HDAC Inhibition in MYC Amplified Medulloblastoma." Neuro-Oncology, vol. 23, no. 2, 2021, https://doi.org/10.1093/neuonc/noaa191.